Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dapagliflozin in Acute Heart Failure (DAPA ACT HF-TIMI 68)
NCT04363697Phase 4Completed
- Sponsor
- TIMI Study Group
- Start
- Sep 2020
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of dapagliflozin in Acute Heart Failure (AHF), sponsored by TIMI Study Group. Started Sep 2020; status: completed.
02
Drugs
dapagliflozin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on NCT04363697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04363697.